334 related articles for article (PubMed ID: 19329206)
1. Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.
Suzuki M; Tanaka H; Sakurai Y; Kashino G; Yong L; Masunaga S; Kinashi Y; Mitsumoto T; Yajima S; Tsutsui H; Sato T; Maruhashi A; Ono K
Radiother Oncol; 2009 Jul; 92(1):89-95. PubMed ID: 19329206
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
[TBL] [Abstract][Full Text] [Related]
3. A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).
Suzuki M; Endo K; Satoh H; Sakurai Y; Kumada H; Kimura H; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Radiother Oncol; 2008 Aug; 88(2):192-5. PubMed ID: 18653257
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
5. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.
Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Ono K; Maruhashi A; Kato I; Fuwa N; Hiratsuka J; Imahori Y
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1523-7. PubMed ID: 17056200
[TBL] [Abstract][Full Text] [Related]
6. A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Jpn J Clin Oncol; 2007 Apr; 37(4):245-9. PubMed ID: 17513310
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
8. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
[TBL] [Abstract][Full Text] [Related]
9. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric evaluation of neutron capture therapy for local advanced breast cancer.
Yanagie H; Kumada H; Sakurai Y; Nakamura T; Furuya Y; Sugiyama H; Ono K; Takamoto S; Eriguchi M; Takahashi H
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S63-6. PubMed ID: 19427224
[TBL] [Abstract][Full Text] [Related]
13. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
14. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma.
Suzuki M; Sakurai Y; Hagiwara S; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Kudo M; Ono K
Jpn J Clin Oncol; 2007 May; 37(5):376-81. PubMed ID: 17578894
[TBL] [Abstract][Full Text] [Related]
15. Feasibility evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion.
Yanagie H; Kumada H; Nakamura T; Higashi S; Ikushima I; Morishita Y; Shinohara A; Fijihara M; Suzuki M; Sakurai Y; Sugiyama H; Kajiyama T; Nishimura R; Ono K; Nakajima J; Ono M; Eriguchi M; Takahashi H
Appl Radiat Isot; 2011 Dec; 69(12):1854-7. PubMed ID: 21752660
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
17. MCNP study for epithermal neutron irradiation of an isolated liver at the Finnish BNCT facility.
Kotiluoto P; Auterinen I
Appl Radiat Isot; 2004 Nov; 61(5):781-5. PubMed ID: 15308144
[TBL] [Abstract][Full Text] [Related]
18. Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT).
Capoulat ME; Minsky DM; Kreiner AJ
Phys Med; 2014 Mar; 30(2):133-46. PubMed ID: 23880544
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
20. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]